ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes
Obecabtagene autoleucel shows promising efficacy and safety in treating relapsed/refractory B-ALL, benefiting patients of all ages, including older adults.
Drawn to Understand: How Culturally Tailored Education Empowers Patients With Type 1 Diabetes
Simplifying complex information through illustrations has consistently helped patients feel that managing type 1 diabetes is achievable.
Study Reveals Alarming Gaps in HER2 Therapy Access for Patients With Breast Cancer
The data revealed that only 75% of patients receive HER2-targeting therapies.
Case-Based Insights on Managing Steroid-Refractory cGVHD After Haploidentical Transplant
Gianni Scappaticci, PharmD, BCOP, outlines a personalized, evidence-based approach to managing steroid-refractory chronic graft-versus-host disease (cGVHD) in a post–haploidentical transplant…
An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial
Host Craig Beavers sits down with Kazuhiko Kido, PharmD, a clinical associate professor at the West Virginia University School of…
CMS launches prior authorization pilot for Original Medicare
The Centers for Medicare and Medicaid Services has announced a prior authorization program pilot for original Medicare.
6.4% payment decrease proposed for home health agencies
Home health agencies are facing a proposed 6.4% decrease in Medicare payments in 2026, compared to 2025.
CMS proposing 1.9% hike for ESRD facilities
The Centers for Medicare and Medicaid Services has issued a proposed rule that would increase total payments to all end-stage…
Fun Fact: Cold Memories Could Warm the Body and Influence Metabolism
A direct link between memories and physical changes has not yet been established.
Patient engagement needs data intelligence
Data gives insights but that information works best when it can be seen by a customer service representative during a…